Your Article Summary
Bayer CropScience acquires US biotech company Athenix Corp
BayNews International, 08/20/09
Bayer CropScience announced today that it has entered into an agreement to purchase Athenix Corp., a privately–held independent biotechnology company headquartered in Research Triangle Park, North Carolina, USA. The acquisition of Athenix and its innovative technology platform will boost Bayer CropScience's ability to make available novel technology and complete agricultural solutions to growers worldwide. The acquisition is subject to premerger notification to the relevant US authorities.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
Article Search
Sponsor


See Latest Articles


